Case Reports
Vol. 10 No. 2 (2018)
https://doi.org/10.4081/dr.2018.7686

Cephalexin-induced acute generalized exanthematous pustulosis

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 18 March 2018
Accepted: 19 July 2018
Published: 1 October 2018
1551
Views
731
Downloads
90
HTML
Tender, Erythematous, Pustular eruption, Drug reaction, Antibiotic.

Authors

Matthew DaCunha
University of Kansas Medical Center, Kansas City, Kansas, United States.
Sarah Moore
University of Kansas Medical Center, Kansas City, Kansas, United States.
David Kaplan
dookdoc@gmail.com
University of Kansas Medical Center, Kansas City, Kansas, United States.
Cephalexin is a cephalosporin antibiotic that is commonly used in the treatment of infectious diseases. We report a patient exhibiting a rare adverse effect of cephalexin: drug-induced Acute Generalized Exanthematous Pustulosis (AGEP). We present this case because of the scarcity of reports associating cephalexin with AGEP in hopes that clinicians will consider AGEP in their differential diagnosis in the appropriate clinical setting.

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite



1.
DaCunha M, Moore S, Kaplan D. Cephalexin-induced acute generalized exanthematous pustulosis. Dermatol Reports [Internet]. 2018 Oct. 1 [cited 2026 May 25];10(2). Available from: https://journals.pagepress.net/dr/article/view/7686